PUBLICATIONS ON GYNECOLOGICAL CANCERS

Coming soon

Záveský L. et al. (2016): Supernatant versus exosomal urinary microRNAs. Two fractions with different outcomes in gynaecological cancers. Neoplasma 63(1):121-132. DOI: 10.4149/neo_2016_015. Download here.

Záveský L. et al. (2016): Cell-free urinary microRNAs expression in small-scale experiments. In book: MicroRNA Detection and Target Identification: Methods and Protocols. Publisher: Springer, Editor: Tamas Dalmay, pp. xx-xx.

Ovarian and Endometrial Cancers

Záveský L. et al. (2015): New perspectives in diagnosis of gynaecological cancers: Emerging role of circulating microRNAs as novel biomarkers. Neoplasma 62(4):509-520. DOI: 10.4149/neo_2015_062. Download here or here.

Záveský L. et al. (2015): Evaluation of Cell-Free Urine microRNAs Expression for the Use in Diagnosis of Ovarian and Endometrial Cancers. A Pilot Study. Pathology & Oncology Research 21(4):1027-1035. Download here or here.

Ovarian cancer

In English

Záveský L. et al. (2015): microRNAs in Diagnosis of Ovarian Cancer. Potential, Challenges, Pitfalls. In book: Ovarian Cancer: Risk Factors, Therapies and Prognosis, Edition: https://www.novapublishers.com/catalog/product_info.php?products_id=56134, Chapter: microRNAs in Diagnosis of Ovarian Cancer. Potential, Challenges, Pitfalls, Publisher: Nova Science Publishers, NY, USA.

Záveský L. et al. (2015): Risk Factors in Ovarian Cancer: A Brief Overview. In book: Ovarian Cancer: Risk Factors, Therapies and Prognosis, Edition: https://www.novapublishers.com/catalog/product_info.php?products_id=56134, Chapter: Risk Factors in Ovarian Cancer: A Brief Overview, Publisher: Nova Science Publishers, Inc., NY, USA.

Záveský L. et al. (2011): Ovarian cancer: Origin and factors involved in carcinogenesis with potential use in diagnosis, treatment and prognosis of the disease. Neoplasma 58(6):457-68. DOI: 10.4149/neo_2011_06_457

Download here.

In Czech

Záveský L. et al. (2015): Rizikové a protektivní faktory u karcinomu ovaria / Risk and protective factors in ovarian cancer. Praktická gynekologie 11/2015; 19(3):35-40. Download here.

Circulating and extracellular miRNAs as new diagnostic biomarkers for gynecological cancers. Praktická gynekologie 12/2014; 18(4):275–280.

Download here.

Záveský L. et al. (2013): Cancer stem cells and ovarian cancer. Characteristics, importance and potential applications in clinical practice. Ceska gynekologie / Ceska lekarska spolecnost J. Ev. Purkyne 01/2013; 78(2):169-174.

Download here.

Záveský L. (2013): Diagnostic tools and prognostic factors in the most malignant gynecological cancer - epithelial ovarian cancer. E-publication online, ISSN 1338-4392, Slovak Medical Chamber, I-med.sk, 2013.

Download here.

Záveský L. et al. (2012): MicroRNAs and their potential in ovarian cancer diagnostics. Current state and possible future. Prakt Gyn 2012; 16(2-4): 59-65.

Download here.

Záveský L. (2012): CA125/MUC16 in diagnosis and prognosis of ovarian cancer. Onkologie (Solen, Czech Republic). 01/2012; 6(2):65-67.

Download here.

Záveský L. (2011): Ovarian cancer – on the road to improved diagnostics and treatment. Interní medicína pro praxi 01/2011; 13(12):490-492.

Download here.

Endometrial cancer

Záveský L. et al. (2013): Differential expression of microRNAs as the novel potential diagnostic tool for the endometrial carcinoma. Ceska gynekologie / Ceska lekarska spolecnost J. Ev. Purkyne 01/2013; 78(5):432-42.

Download here.